Ryan Barnes

Not-Ready-For-Prime-Time Stock List

Really appreciate the input, John. Your comments are right on point. On my second pass over the financials, I see what you're saying. The income statement is like an exercise in LEGO building. Consistent and growing.

The margins have taken a slight hit this year, but then again, it is this year. I can easily forgive some top-line weakness. Cerner looks like they could be a prime beneficiary of healthcare reform, and Obama's stance on EHR is well-documented. The valuation is a bit rich, but balance sheet is stellar as is cash flow. And we all know that a 5 year window of positive catalysts can keep any strong stock in a premium valuation range (25-30x).

I'll be reading through the most recent 10-Q's and K to get a final feel for mgt, but I definitely like to see original founders who have serious skin (and a little pride) still in the game.

Best of luck in your investing efforts,

RB